Celsius (NASDAQ:CELH) Stock Rating Reaffirmed by Wedbush

Wedbush reissued their outperform rating on shares of Celsius (NASDAQ:CELH - Free Report) in a report released on Friday, Benzinga reports. Wedbush currently has a $100.00 price target on the stock.

CELH has been the subject of a number of other research reports. Stifel Europe boosted their target price on Celsius from $90.00 to $95.00 and gave the company a buy rating in a research note on Monday, March 18th. Jefferies Financial Group boosted their price objective on Celsius from $98.00 to $105.00 and gave the company a buy rating in a research report on Monday, March 18th. Morgan Stanley restated an equal weight rating and issued a $75.00 target price on shares of Celsius in a report on Wednesday, March 27th. Stifel Nicolaus lowered their price target on shares of Celsius from $95.00 to $85.00 and set a buy rating for the company in a report on Thursday. Finally, Piper Sandler increased their price target on shares of Celsius from $76.00 to $90.00 and gave the company an overweight rating in a research report on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of Moderate Buy and an average target price of $85.45.

Celsius Price Performance

NASDAQ CELH traded up $1.59 on Friday, reaching $75.97. 4,210,686 shares of the company's stock traded hands, compared to its average volume of 4,620,082. The stock has a market cap of $17.55 billion, a PE ratio of 98.24, a P/E/G ratio of 2.11 and a beta of 1.93. Celsius has a 12 month low of $32.99 and a 12 month high of $99.62. The stock has a 50-day simple moving average of $80.79 and a 200 day simple moving average of $65.47.

Celsius (NASDAQ:CELH - Get Free Report) last released its earnings results on Thursday, February 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The company had revenue of $347.44 million for the quarter, compared to analyst estimates of $326.77 million. During the same quarter last year, the firm earned $0.01 EPS. The firm's quarterly revenue was up 95.2% compared to the same quarter last year. As a group, analysts anticipate that Celsius will post 1.09 EPS for the current year.

Insider Buying and Selling

In other Celsius news, Director Caroline S. Levy sold 20,000 shares of the firm's stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total transaction of $1,895,400.00. Following the completion of the transaction, the director now owns 37,891 shares of the company's stock, valued at $3,590,930.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Jarrod Langhans sold 4,079 shares of the business's stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $69.42, for a total transaction of $283,164.18. Following the sale, the chief financial officer now owns 83,670 shares of the company's stock, valued at $5,808,371.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Caroline S. Levy sold 20,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total transaction of $1,895,400.00. Following the transaction, the director now directly owns 37,891 shares of the company's stock, valued at approximately $3,590,930.07. The disclosure for this sale can be found here. Insiders have sold a total of 1,186,215 shares of company stock valued at $80,215,119 over the last ninety days. Company insiders own 2.20% of the company's stock.

Institutional Trading of Celsius

Hedge funds have recently made changes to their positions in the stock. Cary Street Partners Investment Advisory LLC raised its stake in Celsius by 1,350.0% during the third quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company's stock valued at $25,000 after buying an additional 135 shares during the last quarter. Heritage Wealth Advisors bought a new position in Celsius in the 3rd quarter worth about $32,000. Harvest Fund Management Co. Ltd purchased a new stake in Celsius during the 3rd quarter valued at about $36,000. FinTrust Capital Advisors LLC purchased a new position in Celsius in the first quarter worth about $25,000. Finally, Signaturefd LLC lifted its stake in shares of Celsius by 212.0% in the third quarter. Signaturefd LLC now owns 337 shares of the company's stock worth $58,000 after buying an additional 229 shares in the last quarter. 60.95% of the stock is owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.